24th International Prostate Cancer Update

Vail, CO US
February 19, 2014 to February 22, 2014

Overview

Patterns of care in prostate cancer (PCa) have changed tremendously in the past 20 years, altering the way patients with this tumor present and how they are evaluated before and after diagnosis. With the use of new and combined treatments, the frequency and variety of complications have differed from those previously reported. Advances have been made in PCa imaging, biopsy methodology, in understanding causative factors and disease, in treatment-related quality of life, and in predicting the behavior of individual tumors using risk strata. Despite these advances, no consensus has emerged regarding the optimal treatment for the most common patient with PCa.

There is a need for oncologists, urologists, and nurses to understand the rationale behind targeted therapy for the treatment of advanced PCa, and how trial entry could improve the efficacy of drugs and decrease the toxicity. This activity seeks to educate urologists and other healthcare professionals about the latest advances in the prevention, screening, and treatment of PCa. The International Prostate Cancer Update (IPCU) educational planning committee has identified the following educational gaps between recent research in PCa and its integration into professional practice at the international, national, and community levels:

  • Current best practices in prevention and screening of PCa
  • Promising therapies, issues, and economic concerns in the treatment of local disease
  • Role of newly available therapies in 2014
  • Emerging treatment options for localized, advanced, and castration-resistant PCa

Target Audience

oncologists, urologists, and nurses

Additional information

CME Coordinator Contact Information

Name: 
Linda Caples, MBA
Phone Number: 
+1 (414) 955-7103
Email: 
Course summary
Available credit: 
  • 15.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 15.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
02/17/2014
Course expires: 
12/30/2016
Event starts: 
02/19/2014 - 8:00am
Event ends: 
02/22/2014 - 5:00pm
Cost:
$0.00
Vail Cascade
1300 Westhaven Drive
Vail, CO 81657
United States

To make your hotel reservation, please contact the Cascade at 800-420-2424 and request the Reservations Department. Mention that you are attending the International Prostate Cancer Update Meeting.
 

Accommodations

Vail Cascade
1300 Westhaven Drive
Vail, Colorado 81657

To make your hotel reservation, please contact the Cascade at 800-420-2424 and request the Reservations Department.

A block of rooms has been reserved at the Cascade for the nights of Wednesday, February 19, through Saturday, February 22, at discounted rates, (see list below), single or double occupancy, plus applicable taxes and fees. A limited number of rooms are available for this group, so reservations will be accepted on a first-come, first-served basis.

Room
Rates
Main Lodge$275.00
Deluxe Rooms$324.00
Mountain Grand Fireplace$344.00
Cascade Suites$474.00-$514.00

To receive your discounted rate, please reference the group code "International Prostate Cancer Update." Full payment is required on the date the reservation is made. Full payment for room and tax is refunded if notice is received no later than 30 days in advance of the confirmed arrival date. No shows and early departure/late arrivals will be charged for their full reservation.

Travel

It is recommended that attendees fly into either Denver International Airport (code "DEN") or Eagle County Airport (code "EGE").

The Cascade is located approximately 100 miles west of Denver via Interstate 70 and approximately 35 miles east of the Eagle County Airport via US Highway 6 and Interstate 70.

Ground Transportation

Ground transportation reservations from the airport to the hotel may be made directly through Colorado Mountain Express.

Phone: 800-525-6363
Fax: 970-926-9686
Online: ridecme.com

FACULTY

Program Chair

E. David Crawford, MD
University of Colorado, Denver
Aurora, Colorado



 

Program Committee

James A. Eastham, MD
Memorial Sloan-Kettering Cancer Center
New York, NY
Alan W. Partin, MD, PhD
Johns Hopkins Medical Institutions
Baltimore, MD
Leonard G. Gomella, MD
Thomas Jefferson University
Philadelphia, PA
Daniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT
M. Scott Lucia, MD
University of Colorado, Denver School of Medicine
Aurora, CO
Neal D. Shore, MD
Atlantic Urology Clinics, LLC 
Myrtle Beach, SC

Invited Faculty

Sean P. Collins, MD, PhD
Georgetown University Hospital Washington, DC
Peter F. A. Mulders, MD, PhD
Radboud University Medical Center
Nijmegen, The Netherlands
James A. Eastham, MD
Memorial Sloan-Kettering Cancer Center
New York, NY
Alan W. Partin, MD, PhD
Johns Hopkins Medical Institutions
Baltimore, MD
L. Michael Glodé
University of Colorado, Denver School of Medicine
Aurora, CO
Daniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT
Leonard G. Gomella, MD
Thomas Jefferson University
Philadelphia, PA
Peter A. Pinto, MD
U.S. National Institutes of Health
Bethesda, MD
Aaron E. Katz, MD
Winthrop-University Hospital
Mineola, NY
Matt T. Rosenberg, MD
Urologic Health Foundation
Jackson, Michigan
Thomas E. Keane, MBBCh
Medical University of South Carolina 
Charleston, SC
Neal D. Shore, MD
Atlantic Urology Clinics, LLC 
Myrtle Beach, SC
Phillip J. Koo, MD
University of Colorado, Denver School of Medicine
Aurora, CO
Nelson N. Stone, MD
Mount Sinai School of Medicine
Mount Sinai School of Medicine
New York, NY
M. Scott Lucia, MD
University of Colorado, Denver School of Medicine
Aurora, CO
Priya N. Werahera, PhD
University of Colorado, Denver School of Medicine
Aurora, CO
Brian J. Moran, MD
Chicago Prostate Center
Westmont, IL

Available Credit

  • 15.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 15.25 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
02/17/2014
Course expires: 
12/30/2016

Price

Cost:
$0.00
Please login or register to take this course.